Editor's Note: Ex Vivo Testing of Patient-Derived Xenografts Mirrors the Clinical Outcome of Patients with Pancreatic Ductal Adenocarcinoma
- PMID: 38946291
- DOI: 10.1158/1078-0432.CCR-24-1527
Editor's Note: Ex Vivo Testing of Patient-Derived Xenografts Mirrors the Clinical Outcome of Patients with Pancreatic Ductal Adenocarcinoma
Expression of concern for
-
Ex Vivo Testing of Patient-Derived Xenografts Mirrors the Clinical Outcome of Patients with Pancreatic Ductal Adenocarcinoma.Clin Cancer Res. 2016 Dec 15;22(24):6021-6030. doi: 10.1158/1078-0432.CCR-15-2936. Epub 2016 Jun 3. Clin Cancer Res. 2016. PMID: 27259561 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources